Delsym and Phenergan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Delsym (dextromethorphan polistirex) and Phenergan (promethazine hydrochloride). Common drug interactions include haemodynamic instability among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Delsym and Phenergan. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Delsym?

Delsym has active ingredients of dextromethorphan polistirex. It is often used in cough. eHealthMe is studying from 5,033 Delsym users. Check the latest studies of Delsym.

What is Phenergan?

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.



On Jul, 18, 2026

14 people who take Delsym and Phenergan together, and have interactions are studied.

Delsym and Phenergan drug interactions.

What are the common drug interactions of Delsym and Phenergan, by gender? *:

female:

  1. Haemodynamic instability (disturbances in the blood movement in our body)
  2. Haemorrhage (bleeding)
  3. Hallucinations, mixed (sensations that appear real but are created by your mind -mixed)
  4. White blood cell count increased
  5. Abdominal pain upper
  6. Rhinorrhoea (watery mucus discharge from the nose)
  7. Vertigo
  8. Weight increased
  9. Abdominal pain
  10. Blindness

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hypoxia (low oxygen in tissues)
  3. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Interstitial lung disease
  7. Blood alkaline phosphatase increased
  8. General physical health deterioration (weak health status)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Atypical mycobacterium test positive

What are the common drug interactions of Delsym and Phenergan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Cholecystitis chronic (long lasting infection of gallbladder)
  4. Depression
  5. Gallbladder cholesterolosis (accumulation and deposition of cholesterol inside of the)
  6. Generalised anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
  7. Hepatic steatosis (fatty liver disease)
  8. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  9. White blood cell count increased

40-49:

  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  2. Pitting oedema (skin discoloration)
  3. Pleural effusion (water on the lungs)
  4. Postmenopausal symptoms
  5. Protein total increased
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Tricuspid valve incompetence (inefficient heart valve)
  8. Vestibular disorder (disorders of the body's balance (vestibular) system in the inner ear)
  9. Viral infection
  10. Visual acuity reduced (reduced clearness of vision)

50-59:

n/a

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hypoxia (low oxygen in tissues)
  3. Atypical mycobacterium test positive
  4. Blood albumin decreased
  5. Blood calcium increased
  6. Blood phosphorus increased
  7. Blood pressure systolic increased
  8. Cardiac failure congestive
  9. Cerebral haemorrhage (bleeding within the brain)
  10. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 28.57%
  2. Pain: 2 people, 14.29%
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 14.29%
  4. Weight Decreased: 1 person, 7.14%
  5. Back Pain: 1 person, 7.14%
  6. Blood Potassium Decreased: 1 person, 7.14%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 7.14%
  8. Depression: 1 person, 7.14%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%
  10. Heart Rate Increased: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Delsym and Phenergan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Delsym and Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Delsym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Delsym and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenergan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dextromethorphan polistirex and promethazine hydrochloride (the active ingredients of Delsym and Phenergan, respectively), and Delsym and Phenergan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: